Brief: Strides Pharma Science Dec-Qtr Consol Net Profit 496.7 Mln Rupees
30/01/2024 07:50
Jan 30 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* INDIA’S STRIDES PHARMA SCIENCE DEC-QUARTER CONSOL NET
PROFIT
496.7 MILLION RUPEES VERSUS LOSS 800.3 MILLION RUPEES
* STRIDES PHARMA SCIENCE DEC-QUARTER CONSOL REVENUE FROM
CONTINUING OPERATIONS 10.38 BILLION RUPEES VERSUS 8.65 BILLION
RUPEES
Source text for Eikon: ID:nBSE2NPxSM
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees